Thrombotic complications of tunneled central lines in children with malignancy

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages 88-92

  Ociepa, Tomasz ^a   Maloney, Eliza ^a   Urasinski, Tomasz ^a   Sawicki, Marcin ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Child; Doppler color ultrasound; Malignancy; Thrombosis; Tunneled central line

Indexed keywords

HEPARIN; NADROPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CATHETER OCCLUSION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETERIZATION; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DRUG EFFICACY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SUBCLAVIAN VEIN; TUNNELED CENTRAL LINE; VEIN BLOOD FLOW;

ADOLESCENT; ASPARAGINASE; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 77949448036     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181c09b0c     Document Type: Article

References (25)

1. Skinner R, Koller K, McIntosh N, et al. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer. 2008;50: 826-830.
2. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/ hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648-654.
3. Journeycake JM, Buchanan GR. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol. 2006;24:4575-4580.
4. Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation. 2006;113:e12-e16.
5. Payne JH, Vora AJ. Thrombosis and acute lymphoblastic leukaemia. Br J Haematol. 2007;138:430-445.
6. Ragni MV, Journeycake JM, Brambilla DJ. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis. Haemophilia. 2008; 14:30-38.
7. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. 2001;139:593-596.
8. Svoboda P, Barton RP, Barbarash OL, et al. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med. 2004;32:1990-1996.
9. Chesler L, Feusner JH. Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous catheters. J Pediatr Hematol Oncol. 2002;24:653-656.
10. Molinari AC, Haupt R, Saracco P, et al. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases. Support Care Cancer. 2004;12:840-843.
11. Ruud E, Holmstrom H, Hopp E, et al. Central line-associated venous late effects in children without prior history of thrombosis. Acta Paediatrica. 2006;95:1060-1065.
12. Dubois J, Rypens F, Garel L, et al. Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ. 2007;177:1185-1190.
13. Glaser DW, Medeiros D, Rollins N, et al. Catheter-related thrombosis in children with cancer. J Pediatr. 2001;138: 255-259.
14. Beck C, Dubois J, Grignon A, et al. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care units: a prospective study. J Pediatr. 1998;133: 237-241.
15. Wilimas JA, Hudson M, Rao B, et al. Late vascular occlusion of central lines in pediatric malignancies. Pediatrics. 1998;101:E7.
16. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis and management. Hematol Oncol Clin N Am. 2005;19:182-202.
17. Cesaro S, Tridello G, Cavaliere M, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059-2065.
18. Caruso V, Iacoviello L, Di Castelnouvo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216-2222.
19. Shen V, Li X, Murdock M, et al. Recombinanat tissue plasminogen activator (Alteplase) for restoration of function to occluded central venous catheters in pediatric patients. J Pediatr Hematol Oncol. 2003;25:38-45.
20. Wang M, Hays T, Balasa V, et al. Pediatric coagulation consortium. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003;25:379-386.
21. Journeycake JM, Eshelman D, Buchanan GR. Post-thrombotic syndrome in uncommon in childhood cancer survivors. J Pediatr. 2006;148:275-277.
22. Karthaus M, Kretzschmar A, Kröning H, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a doubleblind, placebo-controlled phase III trial. Ann Oncol. 2006;17: 289-296.
23. Verso M, Agnelli G, Bertoglio S, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol. 2005;23:4057-4062.
24. Couban S, Goodyear M, Burnell M, et al. Randomised placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2005;23:4063-4069.
25. Ruud E, Holmstrøm H, De Lange C, et al. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies-a randomized, controlled study. Acta Paediatr. 2006;95:1053-1059.